Search results for "Sepsi"

showing 10 items of 329 documents

ICU-acquired infections: It is not only about the number of patients per room

2016

LETTER TO EDITOR

Cross infectionmedicine.medical_specialtyCross Infectionbusiness.industryIntensive Care Unit030208 emergency & critical care medicineCritical Care and Intensive Care Medicine03 medical and health sciencesIntensive Care Units0302 clinical medicineText miningEmergency medicineMedicineHumans030212 general & internal medicineMED/41 - ANESTESIOLOGIAbusinessICU acquired infection sepsis critical careHuman
researchProduct

No-touch methods of terminal cleaning in the intensive care unit: results from the first large randomized trial with patient-centred outcomes

2017

N/A

Cross infectionmedicine.medical_specialtySepsiICU-acquired infections; Multidrug resistant organisms; Sepsis; Terminal cleaningIntensive Care UnitMEDLINEMultidrug resistant organismCritical Care and Intensive Care MedicineArticlelaw.inventionSepsis03 medical and health sciencesICU-acquired infection0302 clinical medicineRandomized controlled triallawSepsismedicineHumans030212 general & internal medicineTerminal cleaningIntensive care medicineCross Infectionbusiness.industryMultidrug resistant organismslcsh:Medical emergencies. Critical care. Intensive care. First aid030208 emergency & critical care medicinelcsh:RC86-88.9medicine.diseaseIntensive care unitTerminal cleaningIntensive Care UnitsEmergency medicineICU-acquired infections; Multidrug resistant organisms; Sepsis; Terminal cleaning; Humans; Cross Infection; Intensive Care Units; Critical Care and Intensive Care MedicinebusinessICU-acquired infectionsPatient centredHumanCritical Care
researchProduct

Preventive strategies and factors associated with surgically treated necrotising enterocolitis in extremely preterm infants: an international unit su…

2019

ObjectivesTo compare necrotising enterocolitis (NEC) prevention practices and NEC associated factors between units from eight countries of the International Network for Evaluation of Outcomes of Neonates, and to assess their association with surgical NEC rates.DesignProspective unit-level survey combined with retrospective cohort study.SettingNeonatal intensive care units in Australia/New Zealand, Canada, Finland, Israel, Spain, Sweden, Switzerland and Tuscany (Italy).PatientsExtremely preterm infants born between 240to 286weeks’ gestation, with birth weights<1500 g, and admitted between 2014–2015.ExposuresNEC prevention practices (probiotics, feeding, donor milk) using responses of an o…

Data AnalysisMalePediatricsInternationalityDatabases FactualInfant Premature Diseases2700 General Medicinepaediatric gastroenterologyCohort Studiesperinatology0302 clinical medicineRisk FactorsCause of DeathSurveys and QuestionnairesHospital Mortality1506030212 general & internal medicineOriginal ResearchIncidence (epidemiology)General MedicinePrognosis3. Good healthPrimary PreventionTreatment OutcomeInfant Extremely PrematureCohortGestationFemale1719Cohort studymedicine.medical_specialty610 Medicine & healthneonatologySepsis03 medical and health sciencesEnterocolitis NecrotizingIntensive Care Units Neonatal030225 pediatricsIntensive caremedicineHumansNeonatologyRetrospective Studiesbusiness.industryProbioticsInfant NewbornPaediatricsRetrospective cohort studymedicine.disease10027 Clinic for NeonatologySurvival Analysisdigestive system diseasesbusiness
researchProduct

Expression of P, S, and F1C adhesins by cytotoxic necrotizing factor1-producing Escherichia coli from septicemic and diarrheic pigs

1997

Nineteen papC-positive cytotoxic necrotizing factor 1 (CNF1)-producing Escherichia coli isolates from pigs with septicemia or diarrhea were tested for the presence of pap-, sfa-, and afa-related sequences encoding P/Prs, S/F1C, and Dr/AFA adhesins respectively. Production of adhesins by isolates was tested by mannose-resistant hemagglutination (MRHA), sialidase treatment of erythrocytes and particle agglutination tests. Production of P, S, and F1C fimbriae by isolates was also examined by immunofluorescence. All isolates were pap+ by PCR. Eighteen isolates (95%) were MRHA for ovine and human A erythrocytes and exhibited GalNac-GalNac receptor specificity associated with class III P(Prs) adh…

DiarrheaSerotypeErythrocytesHemagglutinationSwine[SDV]Life Sciences [q-bio]Bacterial ToxinsFimbriaBiologyImmunofluorescencemedicine.disease_causeMicrobiologyMicrobiologyAgglutination TestsSepsisEscherichia coliGeneticsmedicineAnimalsHumansAdhesins BacterialMolecular BiologyEscherichia coliEscherichia coli InfectionsSwine DiseasesAntiserumSheepmedicine.diagnostic_testCytotoxinsEscherichia coli Proteinsbiochemical phenomena metabolism and nutritionBacterial adhesin[SDV] Life Sciences [q-bio]Agglutination (biology)Fimbriae BacterialCattle
researchProduct

Antimicrobial Lessons From a Large Observational Cohort on Intra-abdominal Infections in Intensive Care Units

2021

Severe intra-abdominal infection commonly requires intensive care. Mortality is high and is mainly determined by disease-specific characteristics, i.e. setting of infection onset, anatomical barrier disruption, and severity of disease expression. Recent observations revealed that antimicrobial resistance appears equally common in community-acquired and late-onset hospital-acquired infection. This challenges basic principles in anti-infective therapy guidelines, including the paradigm that pathogens involved in community-acquired infection are covered by standard empiric antimicrobial regimens, and second, the concept of nosocomial acquisition as the main driver for resistance involvement. I…

Drug Resistancemedicine.disease_causeSeverity of Illness Indexlaw.invention0302 clinical medicineENTEROBACTERIACEAElawDrug Resistance Multiple BacterialMedicine and Health SciencesPharmacology (medical)Cross InfectionbiologyBacterialAntimicrobialIntensive care unitAnti-Bacterial AgentsCommunity-Acquired InfectionsEuropeIntensive Care UnitsAnti-Bacterial Agents; Community-Acquired Infections; Critical Illness; Cross Infection; Europe; Humans; Intensive Care Units; Intraabdominal Infections; Microbial Sensitivity Tests; Peritonitis; Sepsis; Severity of Illness Index; Drug Resistance Multiple BacterialESCHERICHIA-COLI030220 oncology & carcinogenesisKLEBSIELLA-PNEUMONIAEBLOOD-STREAM INFECTIONSPYELONEPHRITISMultiplemedicine.medical_specialtyCritical IllnessMicrobial Sensitivity TestsPeritonitisEnterococcus faecalisNO03 medical and health sciencesIntra‑abdominal InfectionsAntibiotic resistanceFOODSepsisIntensive careInternal medicinemedicineHumansFLUOROQUINOLONE RESISTANCEPseudomonas aeruginosabusiness.industrySeptic shockMORTALITYbiology.organism_classificationmedicine.diseaseRISK-FACTORSIntraabdominal Infectionsbusiness030217 neurology & neurosurgeryEnterococcus faecium
researchProduct

Nanomedicine: A Diagnostic and Therapeutic Approach to COVID-19

2021

The SARS-CoV-2 virus is causing devastating morbidity and mortality worldwide. Nanomedicine approaches have a high potential to enhance conventional diagnostics, drugs and vaccines. In fact, lipid nanoparticle/mRNA vaccines are already widely used to protect from COVID-19. In this review, we present an overview of the taxonomy, structure, variants of concern, epidemiology, pathophysiology and detection methods of SARS-CoV-2. The efforts of repurposing, tailoring, and adapting pre-existing medications to battle COVID-19 and the state of vaccine developments are presented. Next, we discuss the broad concepts and limitations of how nanomedicine could address the COVID-19 threat. Nanomaterials …

DrugMedicine (General)Coronavirus disease 2019 (COVID-19)nanotechnologyComputer scienceSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)media_common.quotation_subjectDiagnostic testNanotechnologySARS-CoV-2 virusReviewGeneral Medicineacute respiratory distress syndromesepsisdrug delivery systemsR5-920vaccineMedicineNanomedicineInorganic materialsRepurposingmedia_commonAir filterFrontiers in Medicine
researchProduct

Comparison of DPP‐4 inhibition versus GLP‐1 analogue supplementation on survival and vascular complications in experimental sepsis (145.2)

2014

Background: Dipeptidyl peptidase [DPP]-4 inhibitors are a new class of drug for the treatment of hyperglycemia and recent studies revealed anti-inflammatory effects of these gliptins in experimenta...

DrugPathologymedicine.medical_specialtyendocrine system diseasesbusiness.industrymedia_common.quotation_subjectnutritional and metabolic diseasesPharmacologymedicine.diseaseBiochemistryDipeptidyl peptidaseSepsisGeneticsmedicineGLP-1 AnaloguebusinessMolecular BiologyDipeptidyl peptidase-4Biotechnologymedia_commonThe FASEB Journal
researchProduct

Microcirculatory dysfunction in sepsis: a pathogenetic basis for therapy?

2000

Sepsis is a frequent complication of multiple organ dysfunction syndrome and remains a major problem of intensive care medicine. It is also a common factor in the final cause of death in hospital populations. Clinical observations, assisted by invasive monitoring techniques as well as pathological-anatomical studies, clearly indicate that microcirculatory dysfunction lies at the centre of sepsis pathogenesis. Numerous animal models, from rodents to primates, many of which employ bacteria or their toxins, especially endotoxins, have helped to shed light on the pathomechanisms leading to this dysregulation in the peripheral circulation. Among these are activation of humoral and cellular infla…

Endotheliumbusiness.industryMolecular pathologyOxygen transportBioinformaticsmedicine.diseasePathology and Forensic MedicineMicrocirculationIntracellular signal transductionSepsismedicine.anatomical_structureHeat shock proteinImmunologyMedicinebusinessMultiple organ dysfunction syndromeThe Journal of Pathology
researchProduct

Clinical and immunological aspects of microRNAs in neonatal sepsis

2022

Abstract Neonatal sepsis constitutes a highly relevant public health challenge and is the most common cause of infant morbidity and mortality worldwide. Recent studies have demonstrated that during infection epigenetic changes may occur leading to reprogramming of gene expression. Post-transcriptional regulation by short non-coding RNAs (e.g., microRNAs) have recently acquired special relevance because of their role in the regulation of the pathophysiology of sepsis and their potential clinical use as biomarkers. ~22-nucleotide of microRNAs are not only involved in regulating multiple relevant cellular and molecular functions, such as immune cell function and inflammatory response, but have…

Epigenetic changesInflammationRM1-950BioinformaticsEpigenesis GeneticSepsisImmune systemInfant morbiditymicroRNAmedicineAnimalsHumansEpigeneticsInflammationPharmacologyNeonatal sepsisbusiness.industryInfant NewbornImmunityGeneral MedicinePrognosismedicine.diseaseMicroRNAsGene Expression RegulationNeonatal sepsisTherapeutics. Pharmacologymedicine.symptombusinessReprogrammingBiomarkersBiomedicine & Pharmacotherapy
researchProduct

Monocyte distribution width kinetic after surgery

2022

Not available

Erythrocyte IndicesMDWSepsisBiochemistry (medical)Clinical BiochemistryHumansSurgeryHematologyGeneral MedicineMonocytesBiomarkers
researchProduct